On the other hand, downregulation of S100A9 inhibited cellular proliferation, migration, and tumor formation through inactivating MAPKs and nuclear factor-kappa B (NF-κB) signalings in human osteosarcoma cells [39]. Here, S100A9 is linked to osteosarcoma.